Related Experiment Video

Updated: Aug 6, 2025

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
09:08

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on: June 2, 2021

1.9K

Modulating CD40 and integrin signaling in the proinflammatory nexus using a 15-amino-acid peptide, KGYY15

Gisela M Vaitaitis1, David H Wagner1

  • 1Webb-Waring Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

The Journal of Biological Chemistry
|March 21, 2023
PubMed

Insights

A novel peptide, KGYY15, modulates CD40 signaling to treat type 1 diabetes without immunosuppression. It targets CD40 and associated integrins, offering a promising alternative to antibody blockade for autoimmune diseases.

Area of Science:

  • Immunology
  • Autoimmunity
  • Molecular Biology

Background:

  • CD40 signaling is a key target for treating autoimmune diseases.
  • Previous attempts to block CD40-CD154 interactions with antibodies led to adverse events.
  • A peptide, KGYY15, showed promise in preclinical models by preserving T-cell function.

Purpose of the Study:

  • To elucidate the complex interactions of the CD40 signaling network.
  • To understand the mechanism of action of the peptide KGYY15.
  • To explore potential therapeutic strategies for autoimmune diseases by modulating CD40 signaling.

Main Methods:

  • Protein interaction studies using autoimmune and nonautoimmune mouse models.
  • Analysis of interactions between CD40, CD154, KGYY15, and integrins (CD11a/CD18, CD11b/CD18).

Main Results:

  • Demonstrated novel interactions between CD40 and integrin CD11a/CD18.
  • Confirmed that KGYY15 interacts with both CD40 and integrins CD11a/CD18 and CD11b/CD18.
  • KGYY15 promotes normal effector T-cell levels rather than immunosuppression.

Conclusions:

  • Modulating CD40-CD154 signaling, rather than complete inhibition, may be a safer therapeutic approach.
  • The interaction of KGYY15 with CD40 and integrins offers a new strategy for managing autoimmunity.
  • Preserving normal immunity while treating autoimmune conditions is a key advantage of this approach.
Keywords:
CD40autoimmunityinflammationinhibition mechanismintegrinpeptide interaction

More Related Videos

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes11:48

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes

Published on: May 31, 2018

11.5K
Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation04:15

Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation

Published on: February 2, 2024

1.9K

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.7K
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
3.5K
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
3.4K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K